185
learned that driving diversity is not only the right thing to do, but that it’s also better for business, proven quantitatively through the Diversity Prediction Theorem. The theorem has proven that diversity can improve our bottom line by introducing more perspectives, heuristics, and interpretations into our business challenges. We take this philosophy to heart at Vireo.
OK. As this is an Investor focused publication. Your 2019 Q1 Financials (news release May 31) indicated a pro forma Q1 revenue of approximately $7.0 million (total revenue of $5.8 million increased approximately 57 percent year-over-year). Congratulations are indeed in order on that. What other significant milestones can you quickly highlight?
Well I generally defer to our CEO and CFO on financially focused questions. That said, I left the big CPG world because I strongly believe in the future of cannabis as a positive disruptive force. I believe that Vireo will be a leader in the cannabis industry. Our leadership team has created and enacted a tremendous plan to drive growth. I am confident in our ability to continuously deliver on our promises to patients, providers, and shareholders alike.
Cheers. Before I let you go, is there anything that you would like to bring to the attention of our readers and for anyone interested in Vireo Health? Readers, remember please that I did not spend much time on Vireo’s background and models because they were our feature company in April and May and you encouraged to reference that material.